Reply by Authors.

Saved in:
Bibliographic Details
Title: Reply by Authors.
Authors: Rosenberg S; The Iowa Clinic, West Des Moines, Iowa., Bonten M; Julius Center, UMC Utrecht, Utrecht, Netherlands., Haazen W; Janssen Research & Development, Beerse, Belgium., Spiessens B; Janssen Research & Development, Beerse, Belgium., Abbanat D; Janssen Research & Development LLC, Raritan, New Jersey., Go O; Janssen Research & Development LLC, Raritan, New Jersey., Wagenlehner F; Clinic for Urology, Pediatric Urology and Andrology, Justus-Liebig University, Giessen, Germany., Shore N; Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina., Hagiwara Y; Janssen Pharmaceutical K.K., Tokyo, Japan., Ibarra de Palacios P; Janssen Vaccines, Bern, Switzerland., Geurtsen J; Janssen Vaccines & Prevention B.V., Leiden, Netherlands., Hermans P; Julius Center, UMC Utrecht, Utrecht, Netherlands., Poolman J; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.
Source: The Journal of urology [J Urol] 2021 Mar; Vol. 205 (3), pp. 832. Date of Electronic Publication: 2021 Jan 05.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-3792
DOI:10.1097/JU.0000000000001425.02